We are analyzing https://link.springer.com/article/10.1007/s11745-013-3872-5.

Title:
Conjugated Linoleic Acid Prevents Ovariectomy-Induced Bone Loss in Mice by Modulating Both Osteoclastogenesis and Osteoblastogenesis | Lipids
Description:
Postmenopausal osteoporosis due to estrogen deficiency is associated with severe morbidity and mortality. Beneficial effects of conjugated linoleic acid (CLA) on bone mineral density (BMD) have been reported in mice, rats and humans, but the effect of long term CLA supplementation against ovariectomy-induced bone loss in mice and the mechanisms underlying this effect have not been studied yet. Eight-week old ovariectomized (Ovx) and sham operated C57BL/6 mice were fed either a diet containing 0.5 % safflower oil (SFO) or 0.5 % CLA for 24 weeks to examine BMD, bone turn over markers and osteotropic factors. Bone marrow (BM) cells were cultured to determine the effect on inflammation, osteoclastogenesis, and osteoblastogenesis. SFO/Ovx mice had significantly lower femoral, tibial and lumbar BMD compared to SFO/Sham mice; whereas, no difference was found between CLA/Ovx and CLA/Sham mice. CLA inhibited bone resorption markers whereas enhanced bone formation markers in Ovx mice as compared to SFO-fed mice. Reverse transcriptase polymerase chain reaction and fluorescence activated cell sorting analyses of splenocytes revealed that CLA inhibited pro-osteoclastogenic receptor activator of NF-κB (RANKL) and stimulated decoy receptor of RANKL, osteoprotegerin expression. CLA also inhibited pro-inflammatory cytokine and enhanced anti-inflammatory cytokine production of lipopolysaccharide-stimulated splenocytes and BM cells. Furthermore, CLA inhibited osteoclast differentiation in BM and stimulated osteoblast differentiation in BM stromal cells as confirmed by tartrate resistant acid phosphatase and Alizarin Red staining, respectively. In conclusion, CLA may prevent postmenopausal bone loss not only by inhibiting excessive bone resorption due to estrogen deficiency but also by stimulating new bone formation. CLA might be a potential alternative therapy against osteoporotic bone loss.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 8,170,236 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

pubmed, google, scholar, article, cas, bone, conjugated, linoleic, acid, mice, nutr, rahman, fernandes, central, cla, loss, cells, osteoclastogenesis, estrogen, effect, cell, res, effects, formation, acids, bhattacharya, osteoporosis, osteoprotegerin, differentiation, health, lipids, density, fatty, clin, biochem, body, postmenopausal, mineral, cbl, marrow, osteoclast, interleukin, mass, lacey, dunstan, female, banu, dietary, composition, human,

Topics {✒️}

dual-energy x-ray absorptiometry ovariectomy-induced bone loss month download article/chapter tumor necrosis factor-alpha high-fat-diet-fed mice oliveira-dos-santos aj inhibited pro-inflammatory cytokine estrogen receptor-alpha signaling osteoprotegerin/rankl/rank system gabriel fernandes & paul williams middle-aged female mice insulin-resistant female c57bl/6 t-cell-mediated regulation conjugated linoleic acid full article pdf conjugated linoleic acids bone mineral density osteoporotic bone loss body fat mass vivo body composition n-3 fatty acids bioactive fatty acids polyunsaturated fatty acids opg/ocif inhibits osteoclastogenesis parrish fc jr watkins ba postmenopausal bone loss generalized bone loss bone loss caused visceral fat mass induced jnk activation regulating receptor activator regulates osteoclast differentiation privacy choices/manage cookies estrogen receptor-alpha stimulated osteoblast differentiation md mizanur rahman young male balb/ martin-millan skeletal muscle loss stimulated decoy receptor post-menopausal osteoporosis osteoclastogenesis inhibitory factor osteoclastogenic regulatory molecules halade gv osteoclastic cell differentiation article rahman reduce bone formation significantly lower femoral directly enhancing osteoblastogenesis

Questions {❓}

Wahle KW, Heys SD, Rotondo D (2004) Conjugated linoleic acids: are they beneficial or detrimental to health?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Conjugated Linoleic Acid Prevents Ovariectomy-Induced Bone Loss in Mice by Modulating Both Osteoclastogenesis and Osteoblastogenesis
         description:Postmenopausal osteoporosis due to estrogen deficiency is associated with severe morbidity and mortality. Beneficial effects of conjugated linoleic acid (CLA) on bone mineral density (BMD) have been reported in mice, rats and humans, but the effect of long term CLA supplementation against ovariectomy-induced bone loss in mice and the mechanisms underlying this effect have not been studied yet. Eight-week old ovariectomized (Ovx) and sham operated C57BL/6 mice were fed either a diet containing 0.5 % safflower oil (SFO) or 0.5 % CLA for 24 weeks to examine BMD, bone turn over markers and osteotropic factors. Bone marrow (BM) cells were cultured to determine the effect on inflammation, osteoclastogenesis, and osteoblastogenesis. SFO/Ovx mice had significantly lower femoral, tibial and lumbar BMD compared to SFO/Sham mice; whereas, no difference was found between CLA/Ovx and CLA/Sham mice. CLA inhibited bone resorption markers whereas enhanced bone formation markers in Ovx mice as compared to SFO-fed mice. Reverse transcriptase polymerase chain reaction and fluorescence activated cell sorting analyses of splenocytes revealed that CLA inhibited pro-osteoclastogenic receptor activator of NF-κB (RANKL) and stimulated decoy receptor of RANKL, osteoprotegerin expression. CLA also inhibited pro-inflammatory cytokine and enhanced anti-inflammatory cytokine production of lipopolysaccharide-stimulated splenocytes and BM cells. Furthermore, CLA inhibited osteoclast differentiation in BM and stimulated osteoblast differentiation in BM stromal cells as confirmed by tartrate resistant acid phosphatase and Alizarin Red staining, respectively. In conclusion, CLA may prevent postmenopausal bone loss not only by inhibiting excessive bone resorption due to estrogen deficiency but also by stimulating new bone formation. CLA might be a potential alternative therapy against osteoporotic bone loss.
         datePublished:2013-12-13T00:00:00Z
         dateModified:2013-12-13T00:00:00Z
         pageStart:211
         pageEnd:224
         sameAs:https://doi.org/10.1007/s11745-013-3872-5
         keywords:
            Osteoporosis
            Ovariectomy
            Bone mineral density
            Osteoclastogenesis
            Osteoblastogenesis
            Inflammation
            Lipidology
            Neurochemistry
            Medical Biochemistry
            Nutrition
            Medicinal Chemistry
            Microbial Genetics and Genomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig5_HTML.gif
         isPartOf:
            name:Lipids
            issn:
               1558-9307
               0024-4201
            volumeNumber:49
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Md Mizanur Rahman
               affiliation:
                     name:University of Texas Health Science Center at San Antonio
                     address:
                        name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Gabriel Fernandes
               affiliation:
                     name:University of Texas Health Science Center at San Antonio
                     address:
                        name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Paul Williams
               affiliation:
                     name:University of Texas Health Science Center at San Antonio
                     address:
                        name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Conjugated Linoleic Acid Prevents Ovariectomy-Induced Bone Loss in Mice by Modulating Both Osteoclastogenesis and Osteoblastogenesis
      description:Postmenopausal osteoporosis due to estrogen deficiency is associated with severe morbidity and mortality. Beneficial effects of conjugated linoleic acid (CLA) on bone mineral density (BMD) have been reported in mice, rats and humans, but the effect of long term CLA supplementation against ovariectomy-induced bone loss in mice and the mechanisms underlying this effect have not been studied yet. Eight-week old ovariectomized (Ovx) and sham operated C57BL/6 mice were fed either a diet containing 0.5 % safflower oil (SFO) or 0.5 % CLA for 24 weeks to examine BMD, bone turn over markers and osteotropic factors. Bone marrow (BM) cells were cultured to determine the effect on inflammation, osteoclastogenesis, and osteoblastogenesis. SFO/Ovx mice had significantly lower femoral, tibial and lumbar BMD compared to SFO/Sham mice; whereas, no difference was found between CLA/Ovx and CLA/Sham mice. CLA inhibited bone resorption markers whereas enhanced bone formation markers in Ovx mice as compared to SFO-fed mice. Reverse transcriptase polymerase chain reaction and fluorescence activated cell sorting analyses of splenocytes revealed that CLA inhibited pro-osteoclastogenic receptor activator of NF-κB (RANKL) and stimulated decoy receptor of RANKL, osteoprotegerin expression. CLA also inhibited pro-inflammatory cytokine and enhanced anti-inflammatory cytokine production of lipopolysaccharide-stimulated splenocytes and BM cells. Furthermore, CLA inhibited osteoclast differentiation in BM and stimulated osteoblast differentiation in BM stromal cells as confirmed by tartrate resistant acid phosphatase and Alizarin Red staining, respectively. In conclusion, CLA may prevent postmenopausal bone loss not only by inhibiting excessive bone resorption due to estrogen deficiency but also by stimulating new bone formation. CLA might be a potential alternative therapy against osteoporotic bone loss.
      datePublished:2013-12-13T00:00:00Z
      dateModified:2013-12-13T00:00:00Z
      pageStart:211
      pageEnd:224
      sameAs:https://doi.org/10.1007/s11745-013-3872-5
      keywords:
         Osteoporosis
         Ovariectomy
         Bone mineral density
         Osteoclastogenesis
         Osteoblastogenesis
         Inflammation
         Lipidology
         Neurochemistry
         Medical Biochemistry
         Nutrition
         Medicinal Chemistry
         Microbial Genetics and Genomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11745-013-3872-5/MediaObjects/11745_2013_3872_Fig5_HTML.gif
      isPartOf:
         name:Lipids
         issn:
            1558-9307
            0024-4201
         volumeNumber:49
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Md Mizanur Rahman
            affiliation:
                  name:University of Texas Health Science Center at San Antonio
                  address:
                     name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Gabriel Fernandes
            affiliation:
                  name:University of Texas Health Science Center at San Antonio
                  address:
                     name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Paul Williams
            affiliation:
                  name:University of Texas Health Science Center at San Antonio
                  address:
                     name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Lipids
      issn:
         1558-9307
         0024-4201
      volumeNumber:49
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Texas Health Science Center at San Antonio
      address:
         name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
         type:PostalAddress
      name:University of Texas Health Science Center at San Antonio
      address:
         name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
         type:PostalAddress
      name:University of Texas Health Science Center at San Antonio
      address:
         name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Md Mizanur Rahman
      affiliation:
            name:University of Texas Health Science Center at San Antonio
            address:
               name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Gabriel Fernandes
      affiliation:
            name:University of Texas Health Science Center at San Antonio
            address:
               name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
               type:PostalAddress
            type:Organization
      name:Paul Williams
      affiliation:
            name:University of Texas Health Science Center at San Antonio
            address:
               name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
      name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
      name:Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(258)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.2s.

LINK . SPRINGER . COM {}